Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2023)

引用 0|浏览0
暂无评分
关键词
severe alopecia areata,alopecia areata,eyelash regrowth,deuruxolitinib,eyebrow
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要